Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118306963 | 11830696 | 3 | F | 20151214 | 20151214 | 20160809 | EXP | BE-JNJFOC-20151201778 | JOHNSON AND JOHNSON | VEREECKE G, VERBANCK J. UNEXPLAINED HIGH ANION GAP METABOLIC ACIDOSIS: THE GOLDEN TIP. TIJDSCHRIFT VOOR GENEESKUNDE 15-NOV-2015;71 (22):1501-1505. VEREECKE G, VERBANCK J. UNEXPLAINED ?HIGH ANION GAP METABOLIC ACIDOSIS?: THE GOLDMARK. JOURNAL FOR MEDICINE 2015;71 (22):1501-1505. | 85.00 | YR | E | F | Y | 0.00000 | 20160809 | OT | BE | BE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118306963 | 11830696 | 1 | PS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | N | 19872 | UNSPECIFIED | |||||||||
| 118306963 | 11830696 | 2 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | CHRONIC USAGE. | N | 19872 | UNSPECIFIED | ||||||||
| 118306963 | 11830696 | 3 | I | FLUCLOXACILLIN | FLUCLOXACILLIN | 1 | Intravenous (not otherwise specified) | FOR SEVERAL WEEKS | 0 | 12 | G | UNSPECIFIED | QD | ||||||
| 118306963 | 11830696 | 4 | I | FLUCLOXACILLIN | FLUCLOXACILLIN | 1 | Intravenous (not otherwise specified) | FOR SEVERAL WEEKS | 0 | 12 | G | UNSPECIFIED | QD | ||||||
| 118306963 | 11830696 | 5 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 118306963 | 11830696 | 6 | C | NEBIVOLOL. | NEBIVOLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 118306963 | 11830696 | 7 | C | BUMETANIDE. | BUMETANIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 118306963 | 11830696 | 8 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 118306963 | 11830696 | 9 | C | ORGANIC NITRATES | UNSPECIFIED INGREDIENT | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 118306963 | 11830696 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 118306963 | 11830696 | 11 | C | INSULIN | INSULIN NOS | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118306963 | 11830696 | 2 | Arthralgia |
| 118306963 | 11830696 | 3 | Device related infection |
| 118306963 | 11830696 | 4 | Cardiac failure |
| 118306963 | 11830696 | 5 | Cardiac disorder |
| 118306963 | 11830696 | 6 | Cardiac disorder |
| 118306963 | 11830696 | 7 | Cardiac disorder |
| 118306963 | 11830696 | 8 | Cardiac disorder |
| 118306963 | 11830696 | 9 | Cardiac disorder |
| 118306963 | 11830696 | 10 | Product used for unknown indication |
| 118306963 | 11830696 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118306963 | 11830696 | DE |
| 118306963 | 11830696 | HO |
| 118306963 | 11830696 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118306963 | 11830696 | Cardiogenic shock | |
| 118306963 | 11830696 | Drug interaction | |
| 118306963 | 11830696 | Metabolic acidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |